Drugs Made In America Acquisition II Corp. (DMII)
10.01
0.00 (0.00%)
USD |
NASDAQ |
May 08, 16:00
10.02
+0.01
(+0.10%)
After-Hours: 20:00
Drugs Made In America Acquisition II Enterprise Value : 637.64M for May 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| New Providence Acquisition Corp. III (Cayman Islands) | 395.68M |
| Churchill Capital Corp. XI | 567.40M |
| Compass Diversified Holdings | 3.519B |
| Seaboard Corp. | 5.091B |
| Chase Packaging Corp. | 2.872M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 4.331M |
| Total Expenses (Quarterly) | -4.331M |
| EPS Diluted (Quarterly) | 0.0672 |
| Earnings Yield | 0.65% |
| Normalized Earnings Yield | 0.5894 |